Yaron Segel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The round was led by Hanaco Ventures, alongside Dexcel Pharma, and Peregrine Ventures, bringing the total funding to over $50 million. Funds to be used to support company’s pivotal trials for stroke survivors in U.S. hospitals

United statesNew yorkPasha romanovskiStacey pughYaron segelYotam drechslerDexcel pharmaButterfly networkMedicare coverage of innovative technologyBrainq technologiesHanaco venturesPeregrine venturesSailing capitalTel aviv basedDevice designationMedicare coverage